Key result
Novel lotos PFA catheter maintains one-month PVI in ~92% of targeted veins in swine.
Why the study?
Pulsed field ablation is emerging for pulmonary vein isolation in AF, prompting evaluation of the feasibility and safety of a novel nanosecond-scale lotos PFA catheter system.
Does a novel lotos pulsed field ablation catheter safely and effectively achieve pulmonary vein isolation in a swine model?
Does a novel lotos pulsed field ablation catheter safely and effectively achieve pulmonary vein isolation in a swine model?
A novel lotos pulsed field ablation catheter demonstrated feasibility, safety, and high 30-day efficacy for single-shot pulmonary vein isolation in a swine model.
Supports preclinical feasibility; leaves open human translation and requires clinical trials.
AIMS: Pulsed field ablation (PFA) is emerging as a non-thermal, tissue-specific technique for pulmonary vein isolation (PVI) in atrial fibrillation therapy. This pre-clinical study aims to investigate the feasibility and safety of PVI using a novel PFA system including a nanosecond-scale PFA generator, a novel lotos PFA catheter, and a customized 12 Fr steerable sheath. METHODS AND RESULTS: A total of 11 Yorkshire swine were included in this study, with 4 in the acute cohort and 7 in the chronic cohort. Under general anaesthesia, transseptal puncture and pulmonary vein (PV) angiography was initially performed. The PFA catheter was navigated to position at the right and left PV antrum after the electroanatomic reconstruction of the left atrium. Biphasic PFA applications were performed on PVs in both the spindle-shaped and the lotos-shaped poses. Pulmonary vein isolation and PFA-associated safety were assessed 30 min after ablation in both cohorts and 30 days later in the chronic cohort. Detailed necropsy and histopathology were performed. Additional intracardiac echocardiography and coronary angiogram were evaluated for safety. All target PVs (n = 20) were successfully isolated on the first attempt. No spasm of coronary artery or microbubble was seen during the procedure. Eleven of 12 PVs (91.6%) remained in isolation at the 30-day invasive study. No evidence of PV stenosis was observed in any targets. However, transient diaphragm capture occurred in 17.6%. Histopathological examinations showed no evidence of collateral injury. CONCLUSION: This study provides scientific evidence demonstrating the safety and efficacy of the novel PFA catheter and system for single-shot PVI, which shows great potential.
No takes yet. Share an insight, caveat, or question.
Pu et al. (2023) studied Pulmonary vein isolation (n=11). Novel lotos pulsed field ablation (PFA) catheter system was evaluated on Pulmonary vein isolation at 30 days. A novel lotos pulsed field ablation catheter achieved successful acute pulmonary vein isolation in 100% of targets and maintained isolation in 91.6% of veins at 30 days in a swine model.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: